← All science articles

· 2 min read

Enzyme Purified From Mouse Tumour Cells Reveals Mechanics of DNA Synthesis

By Kristense at Havdis AI Science Team, approved by Andreas Lyhammer

Havdis Arctic PDRN95c against a stormy Norwegian coastline

Based on the PubMed abstract — the full text of this paper was not freely available.

Shepherd and Keir reported in The Biochemical Journal in 1966 a biochemistry study describing the purification and characterization of DNA nucleotidyltransferase (a DNA polymerase) isolated from Landschütz ascites-tumour cells, a mouse cancer cell line grown as ascites fluid. This is laboratory enzymology work using cell extracts, not a clinical or animal-treatment study.

The researchers developed a purification procedure that separated the enzyme from contaminating nucleic acid, triphosphatase, and deoxyribonuclease activities. They found the enzyme worked optimally at pH 7.2–7.4, required a DNA primer (with heat-denatured DNA serving three to ten times more efficiently than native DNA), and needed all four deoxyribonucleoside triphosphates for maximal synthesis of polydeoxyribonucleotide — the general biochemical term used here to describe the enzyme's synthesized product, a chain of linked DNA building blocks, not any therapeutic compound.

The reaction depended on a divalent cation, with magnesium far more effective than manganese, while calcium supported no synthesis at all. Sodium and potassium stimulated activity by 25% and 125% respectively, and EDTA boosted the system five- to ten-fold. The enzyme lost over 95% of its activity after one minute at 45°C unless DNA was present, which conferred heat resistance. The synthesized product was degradable by several nucleases, banded at a density similar to the DNA primer in cesium chloride gradients, and showed nearest-neighbour nucleotide patterns consistent with template-directed synthesis.

The study characterizes an enzyme's biochemical mechanism in isolated cell extracts; it says nothing about intact organisms, tissue effects, or any therapeutic application.

Our reflection

This 1966 paper sits at the foundational end of DNA biochemistry, decades before PDRN as a marine-derived material was studied for its own properties. It uses "polydeoxyribonucleotide" purely as a technical term for an enzyme's synthetic product in a mouse tumour-cell extract, with no connection to skin, wound biology, or any application relevant to Havdis. We note it mainly as a marker of how long researchers have been probing the basic chemistry of DNA strand synthesis — groundwork that underlies the field's later maturity.

Source

Shepherd JB, Keir HM (1966). The Biochemical journal.

Read the paper on PubMedDOI: 10.1042/bj0990443Free full text (PMC)

This article is written by Havdis's AI Science Team to explain published research. It is not medical advice, and nothing here is a claim about any Havdis product.

From research to ingredient

Developing with PDRN? Let’s talk.